In the Italian pharmaceutical sector, the share of corresponding or leading authors in scientific publications has seen a consistent growth from 2024 to 2028, projected from 91.23% in 2024 to 91.57% in 2028. These forecasted data indicate a modest year-on-year increase, suggesting continued consolidation of attribution and recognition practices within pharmaceuticals. Comparatively, the CAGR reflects a stable yet incremental enhancement in author representation over the next five years, marking a favorable trend for authorship accountability.
Future trends to watch for include the potential impacts of technology and collaboration on author contributions. As multidisciplinary approaches and digital platforms evolve, the landscape may shift, possibly affecting the distribution and recognition of leading authorship in scholarly outputs.
